Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05496972

Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology

To understand more about the opinions of patients and health providers on the use of telemedicine in radiation oncology.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Hematopoietic and Lymphoid Cell Neoplasm Hematologic Diseases Hematologic Neoplasms Hemic and Lymphatic Diseases Malignant Solid Neoplasm Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

About this study

Primary Objective:

To characterize patient and provider satisfaction with telemedicine in RO

Secondary Objective:

  • To provide evidence for or against the use of telemedicine in radiation oncology (RO)
  • To assess the feasibility of and value added by telemedicine in RO
  • To describe barriers and facilitators to telemedicine in RO
  • To identify preferred use cases for telemedicine in RO

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients will be eligible if they are aged 18 or older and have undergone at least 1 telemedicine encounter (video visit) with the radiation oncology department at MD Anderson or its affiliates within 2 months from the initiation of the study (and prospectively as the study enrolls). This would include weekly see visits, follow-up visits, or consultations
  • English speaking
  • Access to email and internet to complete the survey
  • Attending physicians in the radiation oncology department who have utilized telemedicine will be contacted to fill out surveys reflecting their experience

Exclusion criteria

  • Protected populations such as adults unable to consent, pregnant women, prisoners, and individuals who are not yet adults will be excluded

Treatment and study plan

Survey Administration

Behavioral

Patients and providers complete survey over 10 minutes about their perspectives on the use of telemedicine

Primary outcomes

  1. Patient satisfaction survey with telemedicine in radiation oncology (RO)

    Time frame: through study completion and average of one year.

    Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers.

  2. Provider satisfaction survey with telemedicine in radiation oncology (RO)

    Time frame: through study completion and average of one year.

    Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers.

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2021
Primary completion
2027
Study completion
2027
First posted
Aug 11, 2022
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.